Screening

Nuclear Matrix Proteins Detected in Blood of Women with Early Stage Breast Cancer

Published in Women's Health Weekly, March 25th, 2000

Matritech, Inc., Newton, Massachusetts, announced that its scientists had detected the presence of nuclear matrix proteins (NMP) in the blood of women even at the earliest stages of breast cancer, but absent in the blood of normal women as well as those with fibroadenoma, a benign breast disease.

Using its proprietary specimen preparation and mass spectrometry procedures to test the blood from each woman, the scientific team led by Brynmor Watkins, PhD, confirmed the presence of NMPs in the blood from women with breast cancer, at all stages of the disease. The scientists have selected one of the NMPs, NMP66, for further development and clinical trials of a test kit for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2000-03-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry